Clin2
NCT07028710Possibly a fitRecruiting

Progesterone changes after hCG-triggered ovulation in natural cycles

Luteal Phase Insufficiency

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study looks at how progesterone levels change in the early part of the luteal phase (after ovulation) when ovulation is triggered by an hCG injection in a natural cycle. It may help women undergoing routine ovulation induction understand how their body responds.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
Any age
Study type
Interventional

Who can take part

  • You must have at least one follicle (egg sac) that is 14 mm or larger.
  • Your uterine lining must be at least 6 mm thick.
  • At the start of your cycle (day 1–4), your LH level was less than double the normal and your progesterone level was below 1.5 ng/mL.
  • You are scheduled to receive an hCG shot (like Ovitrelle) to trigger ovulation as part of your regular treatment.
  • You cannot be using any progesterone medication (vaginal, injectable, or synthetic) that might interfere with the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07613528Not yet recruiting· Phase 3
Extra Progesterone Support for IVF Pregnancies With Low Levels

This study tests whether giving extra progesterone injections under the skin helps pregnancies succeed after IVF when progesterone levels are low. You'd already be pregnant from IVF and have a low progesterone result to qualify.

Montpellier
NCT06928844Recruiting
Low dose progesterone injection for ovulation

This trial tests whether a low dose of progesterone (a hormone) can help trigger ovulation in women who have trouble getting pregnant. It may offer a new option for women with infertility.

Cairo
NCT07466199Not yet recruiting· Phase 4
Progesterone as ovulation trigger for egg donors

This trial uses a hormone called progesterone as a trigger for ovulation in egg donors, instead of the usual hCG. It may help lower the risk of ovarian hyperstimulation syndrome while still producing mature eggs for donation.

Lisbon
NCT06150703Recruiting· Phase 3
Luteal phase support with GnRH agonist after egg retrieval trigger

This trial tests whether giving a medication called a GnRH agonist during the luteal phase (the time after egg retrieval) can help with IVF success. It is for people who are using a specific medication protocol (recombinant FSH with an antagonist) and have certain hormone levels.

Bondy
NCT07508657Not yet recruiting· Phase 4
Progesterone after letrozole for intrauterine insemination

This trial tests whether taking progesterone after a type of fertility treatment called IUI can improve success rates. The study focuses on people who are using a drug called letrozole to stimulate the ovaries.

Copenhagen
NCT05569577Recruiting
Extra hCG injections to help pregnancy in IHH

This trial studies whether adding extra hCG shots improves pregnancy outcomes for people diagnosed with IHH, a hormone-related cause of not starting periods. If you’re trying to get pregnant, it may help test whether this added treatment improves your chances.

Shanghai, Shanghai Municipality

Hear when a new Luteal Phase Insufficiency trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.